A Clinical Study to Evaluate the Safety and Efficacy of T92 in Pediatric Patients With Tourette Syndrome
Clinical trial NCT05188274 · UNKNOWN
Trial details
- NCT number
- NCT05188274
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2024-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.